Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/25 19:40 | 8/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO | 2 | M.d | 28 | 1.32 | 0 | 21 | 8 | 278 | D | ||||||||||||||
8/19/25 19:40 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO | 2 | S.d | -28 | 1.32 | 0 | -21 | 278 | D | |||||||||||||||
8/19/25 19:38 | 8/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC,Secre | 2 | M.d | 30 | 1.80 | 0 | 16 | 43 | 55 | D | ||||||||||||||
8/19/25 19:38 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC,Secre | 2 | S.d | -30 | 1.80 | 0 | -16 | 55 | D | |||||||||||||||
8/19/25 19:37 | 8/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 2 | M.d | 109 | 2.28 | 0 | 48 | 3 | 1,770 | D | ||||||||||||||
8/19/25 19:37 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 2 | S.d | -109 | 2.28 | 0 | -48 | 1,770 | D | |||||||||||||||
8/19/25 19:36 | 8/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 2 | M.d | 25 | 1.78 | 0 | 14 | 52 | 42 | D | ||||||||||||||
8/19/25 19:36 | 8/18/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 2 | S.d | -25 | 1.78 | 0 | -14 | 42 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |